Andrew S. Wellin’s antitrust practice includes regulatory counseling on mergers and acquisitions before federal, state, and international competition authorities as well as private antitrust litigation in the federal and state courts. Drew also has extensive experience counseling clients on the antitrust risk arising from settlement agreements between pioneer and generic pharmaceutical manufacturers involved in Hatch-Waxman Act patent infringement litigation.
Prior to joining Morgan Lewis, Drew worked as an associate in the antitrust group at a major international law firm located in New York. Additionally, immediately following his graduation from law school, Drew was appointed Special Assistant Corporation Counsel at the Office of the Corporation Counsel of the City of New York in the Appeals Division. During that time, Drew briefed dozens of appeals on behalf of the City and successfully argued numerous cases before the US Court of Appeals for the Second Circuit and New York’s Appellate Division.
Brooklyn Law School, 2010, J.D., Cum Laude, Order of Barristers
The Colorado College, 2002, B.A., History
U.S. Court of Appeals for the Second Circuit
U.S. District Court for the Southern District of New York
U.S. District Court for the Eastern District of New York
Awards and Affiliations
Member, Practice Group of the Year, Competition, Law360 (2017)
Recognized, US News & World Report and Best Lawyers 2017 Practice Group of the Year for Antitrust Law
Recognized, New York Metro Super Lawyers "Rising Stars" for Antitrust (2014, 2015)
Member, Antitrust Section, American Bar Association